¿Cuáles son los factores de riesgo modificables que previenen el deterioro cognitivo y la demencia?

[1] Prince M, Guerchet M, Prina M. The Epidemiology and Impact of Dementia: Current State and Future Trends. Geneva: World Health Organization; 2015.
[2] Prince M, Guerchet M, Prina M, Alzheimer’s Disease International. Policy Brief for Heads of Government: The Global Impact of Dementia 2013-2050. London: Alzheimer’s Disease International; 2013.
[3] G8 Dementia Summit Communique. Available at: www.gov.uk/
government/uploads/system/uploads/attachment_data/file/265868/
2901669_G8_DementiaSummitCommunique_acc.pdf. Accessed on April 7, 2015.
[4] UK Health Forum. Promoting brain health: Developing a prevention agenda linking dementia and other non-communicable diseases. London: UK Health Forum; 2014.
[5] Woodward M. Dementia Risk Reduction: The Evidence. Scullin, Australia: Alzheimer’s Australia; 2007. Paper 13.
[6] Farrow M, O’Connor E. Targeting Brain, Body and Heart for Cognitive Health and Dementia Prevention: Current Evidence and Future Directions. Canberra, Australia: Alzheimer’s Australia; 2012. Paper 29.
[7] Prince M, Albanese E, Guerchet M, Prina M. Dementia and Risk Reduction: An Analysis of Protective and Modifiable Factors. London: Alzheimer’s Disease International; 2014. World Alzheimer’s Report 2014.
[8] Barnes DE, Yaffe K. The projected effect of risk factor reduction on Alzheimer’s disease prevalence. Lancet Neurol 2011; 10:819–28.
[9] Alzheimer’s Association. 2014 Alzheimer’s Disease Facts and Figures. Alzheimers Dement 2014; 10:e47–92.
[10] Hebert LE, Bienias JL, Aggarwal NT, Wilson RS, Bennett DA, Shah RC, et al. Change in risk of Alzheimer disease over time. Neurology 2010; 75:786–91.
[11] Hebert LE,Weuve J, Scherr PA, Evans DA. Alzheimer disease in the United States (2010-2050) estimated using the 2010 census. Neurology 2013; 80:1778–83.
[12] Green RC, Cupples LA, Go R, Benke KS, Edeki T, Griffith PA, et al. Risk of dementia among white and African American relatives of patients with Alzheimer disease. JAMA 2002; 287:329–36.
[13] Fratiglioni L, Ahlbom A, Viitanen M, Winblad B. Risk factors for late-onset Alzheimer’s disease: A population-based, case-control study. Ann Neurol 1993; 33:258–66.
[14] Mayeux R, Sano M, Chen J, Tatemichi T, Stern Y. Risk of dementia in first-degree relatives of patients with Alzheimer’s disease and related disorders. Arch Neurol 1991; 48:269–73.
[15] Lautenschlager NT, Cupples LA, Rao VS, Auerbach SA, Becker R, Burke J, et al. Risk of dementia among relatives of Alzheimer’s disease patients in the MIRAGE Study: What is in store for the oldest old? Neurology 1996; 46:641–50.
[16] Saunders AM, Strittmatter WJ, Schmechel D, George-Hyslop PH, Pericak-Vance MA, Joo SH, et al. Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer’s disease. Neurology 1993; 43:1467–72.
[17] Farrer LA, Cupples LA, Haines JL, Hyman B, Kukull WA, Mayeux R, et al. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease: A metaanalysis. JAMA 1997; 278:1349–56.
[18] National Institutes of Health. NIH Consensus Development Conference Statement on Preventing Alzheimer’s Disease and Cognitive Decline. Bethesda, MD: National Institutes of Health; 2010.
[19] Lu FP, Lin KP, Kuo HK. Diabetes and the risk of multi-system aging phenotypes: A systematic review and meta-analysis. PLoS One 2009; 4:e4144.
[20] Profenno LA, Porsteinsson AP, Faraone SV. Meta-analysis of Alzheimer’s disease risk with obesity, diabetes, and related disorders. Biol Psychiatry 2010; 67:505–12.
[21] Biessels GJ, Staekenborg S, Brunner E, Brayne C, Scheltens P. Risk of dementia in diabetes mellitus: A systematic review. Lancet Neurol 2006; 5:64–74.
[22] Kloppenborg RP, van den Berg E, Kappelle LJ, Biessels GJ. Diabetes and other vascular risk factors for dementia: Which factor matters most? A systematic review. Eur J Pharmacol 2008; 585:97–108.
[23] Cheng G, Huang C, Deng H, Wang H. Diabetes as a risk factor for dementia and mild cognitive impairment: A meta-analysis of longitudinal studies. Intern Med J 2012; 42:484–91.
[24] Gudala K, Bansal D, Schifano F, Bhansali A. Diabetes mellitus and risk of dementia: A meta-analysis of prospective observational studies. J Diabetes Investig 2013; 4:640–50.
[25] Roberts RO, Knopman DS, Cha RH, Mielke MM, Pankratz VS, Boeve BF, et al. Diabetes and elevated hemoglobin A1c levels are associated with brain hypometabolism but not amyloid accumulation. J Nucl Med 2014; 55:759–64.
[26] Plassman BL, Williams JW Jr, Burke JR, Holsinger T, Benjamin S. Systematic review: factors associated with risk for and possible prevention of cognitive decline in later life. Ann Intern Med 2010; 153:182–93.
[27] Cooper C, Sommerlad A, Lyketsos CG, Livingston G. Modifiable predictors of dementia in mild cognitive impairment: a systematic review and meta-analysis. Am J Psychiatry 2015; 172:323–34.
[28] Mushtag G, Khan JA, Kamal MA. Biological mechanisms linking Alzheimer’s disease and Type-2 Diabetes mellitus. CNS Neurol Disord Drug Targets 2014; 13:1192–201.
[29] De Felice FG, Ferreira ST. Inflammation, defective insulin signaling, and mitochondrial dysfunction as common molecular denominators connecting type 2 diabetes to Alzheimer disease. Diabetes 2014; 63:2262–72.
[30] Yang Y, Song W. Molecular links between Alzheimer’s disease and diabetes mellitus. Neuroscience 2013; 250:140–50.
[31] Sellbom KS, Gunstad J. Cognitive function and decline in obesity. J Alzheimers Dis 2012;30(Suppl 2):S89–95.
[32] Beydoun MA, Beydoun HA, Wang Y. Obesity and central obesity as risk factors for incident dementia and its subtypes: A systematic review and meta-analysis. Obes Rev 2008; 9:204–18.
[33] Loef M,Walach H. Midlife obesity and dementia: Meta-analysis and adjusted forecast of dementia prevalence in the United States and China. Obesity (Silver Spring) 2013; 21:E51–5.
34] Anstey KJ, Cherbuin N, Budge M, Young J. Body mass index in midlife and late-life as a risk factor for dementia: A meta-analysis of prospective studies. Obes Rev 2011; 12:e426–37.
[35] Lee Y, Back JH, Kim J, Kim SH, Na DL, Cheong HK, et al. Systematic review of health behavioral risks and cognitive health in older adults. Int Psychogeriatr 2010; 22:174–87.
[36] Gustafson DR, Backman K, Joas E, Waern M, Ostling S, Guo X, et al. 37 years of body mass index and dementia: Observations from the prospective population study of women in Gothenburg, Sweden. J Alzheimers Dis 2012; 28:163–71.
[37] Luchsinger JA, Patel B, Tang MX, Schupf N, Mayeux R. Measures of adiposity and dementia risk in elderly persons. Arch Neurol 2007; 64:392–8.
[38] Fitzpatrick AL, Kuller LH, Lopez OL, Diehr P, O’Meara ES, Longstreth WT Jr, et al. Midlife and late-life obesity and the risk of dementia: Cardiovascular health study. Arch Neurol 2009; 66:336–42.
[39] Barnes DE, Covinsky KE, Whitmar RA, Kuller LH, Lopez OL, Yaffe K. Predicting risk of dementia in older adults: the late-life dementia risk index. Neurology 2009; 73:173–9.
[40] Dahl AK, Lopponen M, Isoaho R, Berg S, Kivela SL. Overweight and obesity in old age are not associated with greater dementia risk. J Am Geriatr Soc 2008; 56:2261–6.
[41] Gustafson DR, Luchsinger JA. High adiposity: Risk factor for dementia and Alzheimer’s disease? Alzheimers Res Ther 2013; 5:57.
[42] Qizilbash N, Gregson J, Johnson ME, Pearce N, Douglas I, Wing K, et al. BMI and risk of dementia in two million people over two decades: a retrospective cohort study. Lancet Diabetes Endocrinol 2015; http://dx.doi.org/10.1016/52213-8587(15)00033-9. Epub ahead of print.
[43] Power MC, Weuve J, Gagne JJ, McQueen MB, Viswanathan A, Blacker D. The association between blood pressure and incident Alzheimer disease: A systematic review and meta-analysis. Epidemiology 2011; 22:646–59.
[44] McGuinness B, Todd S, Passmore P, Bullock R. Blood pressure lowering in patients without prior cerebrovascular disease for prevention of cognitive impairment and dementia. Cochrane Database Syst Rev 2009; (4)::CD004034.
[45] Shah K, Qureshi SU, Johnson M, Parikh N, Schulz PE, Kunik ME. Does use of antihypertensive drugs affect the incidence or progression of dementia? A systematic review. Am J Geriatr Pharmacother 2009; 7:250–61.
[46] Guan JW, Huang CQ, Li YH, Wan CM, You C, Wang ZR, et al. No association between hypertension and risk for Alzheimer’s disease: A meta-analysis of longitudinal studies. J Alzheimers Dis 2011; 27:799–807.
[47] Sharp SI, Aarsland D, Day S, Sonnesyn H, Ballard C, Alzheimer’s Society Vascular Dementia Systematic Review Group. Hypertension is a potential risk factor for vascular dementia: Systematic review. Int J Geriatr Psychiatry 2011; 26:661–9.
[48] Rouch L, Cestac P, Hanon O, Cool C, Helmer C, Bouhanick B, et al. Antihypertensive drugs, prevention of cognitive decline and dementia: a systematic review of observational studies, randomized controlled trials and meta-analyses, with discussion of potential mechanisms. CNS Drugs 2015; 29:113–30.
[49] Chang-Quan H, Hui W, Chao-Min W, Zheng-Rong W, Jun-Wen G, Yong-Hong L, et al. The association of antihypertensive medication use with risk of cognitive decline and dementia: a meta-analysis of longitudinal studies. Int J Clin Pract 2011; 65:1295–305.
[50] Kennelly SP, Lawlor BA, Kenny RA. Blood pressure and the risk for dementia: A double edged sword. Ageing Res Rev 2009; 8:61–70.
[51] Corrada M, Hayden KM, Bullain SS, Paganini-Hill A, DeMoss J, Aguirre C, et al. Age of onset of hypertension and risk of dementia in the oldest-old: The 901 study. Alzheimers Dement 2014; 10(4 Supplement):P501.
[52] Anstey KJ, Lipnicki DM, Low LF. Cholesterol as a risk factor for dementia and cognitive decline: A systematic review of prospective studies with meta-analysis.AmJ Geriatr Psychiatry 2008; 16:343–54.
[53] Kivipelto M, Solomon A. Cholesterol as a risk factor for Alzheimer’s disease – epidemiological evidence. Acta Neurol Scand Suppl 2006; 185:50–7.
[54] Muangpaisan W, Brayne C, Alzheimer’s Society Vascular Dementia Systematic Review Group. Systematic review of statins for the prevention of vascular dementia or dementia. Geriatr Gerontol Int 2010; 10:199–208.
[55] Beri A, Sural N, Mahajan SB. Non-atheroprotective effects of statins: A systematic review. Am J Cardiovasc Drugs 2009; 9:361–70.
[56] McGuinness B, CraigD, Bullock R, Passmore P. Statins for the prevention of dementia. Cochrane Database Syst Rev 2009; (2):CD003160.
[57] Richardson K, Schoen M, French B, Umscheid CA, Mitchell MD, Arnold SE, et al. Statins and cognitive function: a systematic review. Ann Intern Med 2013; 159:688–97.
[58] Ligthart SA, Moll van Charante EP, Van GoolWA, Richard E. Treatment of cardiovascular risk factors to prevent cognitive decline and dementia: a systematic review. Vasc Health Risk Manag 2010; 6:775–85.
[59] Anstey KJ, von Sanden C, Salim A, O’Kearney R. Smoking as a risk factor for dementia and cognitive decline: A meta-analysis of prospective studies. Am J Epidemiol 2007; 166:367–78.
[60] Cataldo JK, Prochaska JJ, Glantz SA. Cigarette smoking is a risk factor for Alzheimer’s disease: An analysis controlling for tobacco industry affiliation. J Alzheimers Dis 2010; 19:465–80.
[61] Peters R, Poulter R, Warner J, Beckett N, Burch L, Bulpitt C. Smoking, dementia and cognitive decline in the elderly: A systematic review. BMC Geriatr 2008; 8:36.
[62] Beydoun MA, Beydoun HA, Gamaldo AA, Teel A, Zonderman AB, Wang Y. Epidemiologic studies of modifiable factors associated with cognition and dementia: Systematic review and meta-analysis. BMC Public Health 2014; 14:643.
[63] McKenzie J, Bhatti L, Tursan d’Espaignet E. WHO Tobacco Knowledge Summaries: Tobacco and Dementia. Geneva: World Health Organization; 2014.
[64] Zhong G, Wang Y, Zhang Y, Guo JJ, Zhao Y. Smoking is associated with an increased risk of dementia: A meta-analysis of prospective cohort studies with investigation of potential effect modifiers. PLoS One 2015; 10:e0118333.
[65] Sabia S, Elbaz A, Dugravot A, Head J, Shipley M, Hagger-Johnson G, et al. Impact of smoking on cognitive decline in early old age: The Whitehall II cohort study. Arch Gen Psychiatry 2012; 69:627–35.
[66] Rusanen M, Kivipelto M, Quesenberry CP Jr, Zhou J, Whitmer RA. Heavy smoking in midlife and long-term risk of Alzheimer disease and vascular dementia. Arch Intern Med 2011; 171:333–9.
[67] Rolland Y, Abellan van Kan G, Vellas B. Physical activity and Alzheimer’s disease: From prevention to therapeutic perspectives. J Am Med Dir Assoc 2008; 9:390–405.
[68] Hamer M, Chida Y. Physical activity and risk of neurodegenerative disease: A systematic review of prospective evidence. Psychol Med 2009; 39:3–11.
[69] Paterson DH,Warburton DE. Physical activity and functional limitations in older adults: A systematic review related to Canada’s Physical Activity Guidelines. Int J Behav Nutr Phys Act 2010; 7:38.
[70] Lautenschlager NT, Cox KL, Flicker L, Foster JK, van Bockxmeer FM, Xiao J, et al. Effect of physical activity on cognitive function in older adults at risk for Alzheimer disease: A randomized trial. JAMA 2008; 300:1027–37.
[71] Sofi F, Valecchi D, Bacci D, Abbate R, Gensini GF, Casini A, et al. Physical activity and risk of cognitive decline: A meta-analysis of prospective studies. J Intern Med 2011; 269:107–17.
[72] Blondell SJ, Hammersley-Mather R, Veerman JL. Does physical activity prevent cognitive decline and dementia? A systematic review and meta-analysis of longitudinal studies. BMC Public Health 2014; 14:510.
[73] Ahlskog JE, Geda YE, Graff-Radford NR, Petersen RC. Physical exercise as a preventive or disease-modifying treatment of dementia and brain aging. Mayo Clin Proc 2011;86:876–84.
[74] Colcombe S, Kramer AF. Fitness effects on the cognitive function of older adults: a meta-analytic study. Psychol Sci 2003; 14:125–30.
[75] Smith PJ, Blumenthal JA, Hoffman BM, Cooper H, Strauman TA, Welsh-Bohmer K, et al. Aerobic exercise and neurocognitive performance: a meta-analytic review of randomized controlled trials. Psychosom Med 2010; 72:239–52.
[76] Bherer L, Erickson KI, Liu-Ambrose T. A review of the effects of physical activity and exercise on cognitive and brain functions in older adults. J Aging Res 2013; 2013:657508.
[77] Angevaren M, Aufdemkampe G, Verhaar HJ, Aleman A, Vanhees L. Physical activity and enhanced fitness to improve cognitive function in older people without known cognitive impairment. Cochrane Database Syst Rev 2008;(3)::CD005381.
[78] Barnes DE, Santos-Modesitt W, Poelke G, Kramer AF, Castro C, Middleton LE, et al. The Mental Activity and eXercise (MAX) trial: A randomized controlled trial to enhance cognitive function in older adults. JAMA Intern Med 2013; 173:797–804.
[79] Lourida I, Soni M, Thompson-Coon J, Purandare N, Lang IA, Ukoumunne OC, et al. Mediterranean diet, cognitive function, and dementia: A systematic review. Epidemiology 2013; 24:479–89.
[80] Psaltopoulou T, Sergentanis TN, Panaqiotakos DB, Sergentanis IN, Kosti R, Scarmeas N. Mediterranean diet, stroke, cognitive impairment, and depression: A meta-analysis. Ann Neurol 2013; 74:580–91.
[81] Morris MC, Tangney CC, Wang Y, Sacks FM, Bennett DA, Aggarwal NT. MIND diet associated with reduced incidence of Alzheimer’s disease. Alzheimers Dement 2015; http://dx.doi.org/ 10.1016/j.jalz.2014.11.009. Epub ahead of print.
[82] Anstey KJ, Mack HA, Cherbuin N. Alcohol consumption as a risk factor for dementia and cognitive decline: Meta-analysis of prospective studies. Am J Geriatr Psychiatry 2009; 17:542–55.
[83] Peters R, Peters J,Warner J, Beckett N, Bulpitt C. Alcohol, dementia and cognitive decline in the elderly: Asystematic review. Age Ageing
2008; 37:505–12.
[84] Neafsey EJ, Collins MA. Moderate alcohol consumption and cognitive risk. Neuropsychiatr Dis Treat 2011; 7:465–84.
[85] Mukamal KJ, Mittleman MA, Longstreth WT Jr, Newman AB, Fried LP, Siscovick DS. Self-reported alcohol consumption and falls in older adults: Cross-sectional and longitudinal analyses of the Cardiovascular Health Study. J Am Geriatr Soc 2004; 52:1174–9.
[86] Stahre M, Roeber J, Kanny D, Brewer RD, Zhang X. Contribution of excessive alcohol consumption to deaths and years of potential life lost in the United States. Prev Chronic Dis 2014; 11:E109.
[87] U.S. Department of Agriculture and U.S. Department of Health and Human Services. Dietary Guidelines for Americans, 2010. 7th ed. Washington, DC: U.S. Government Printing Office; 2010.
[88] Martin M, Clare L, Altgassen AM, Cameron MH, Zehnder F. Cognition- based interventions for healthy older people and people with mild cognitive impairment. Cochrane Database Syst Rev 2011;(1)::CD006220.
[89] Stern C, Munn Z. Cognitive leisure activities and their role in preventing dementia: A systematic review. Int J Evid Based Healthc 2010; 8:2–17.
[90] Valenzuela M, Sachdev P. Can cognitive exercise prevent the onset of dementia? Systematic review of randomized clinical trials with longitudinal follow-up. Am J Geriatr Psychiatry 2009; 17:179–87.
[91] Fratiglioni L, Paillard-Borg S, Winblad B. An active and socially integrated
lifestyle in late life might protect against dementia. Lancet Neurol 2004; 3:343–53.
[92] James BD,Wilson RS, Barnes LL, Bennett DA. Late-life social activity and cognitive decline in old age. J Int Neuropsychol Soc 2011; 17:998–1005.
[93] Noice T, Noice H, Kramer AF. Participatory arts for older adults: a review of benefits and challenges. Gerontologist 2014; 54:741–53.
[94] Ertel KA, Glymour MM, Berkman LF. Effects of social integration on preserving memory function in a nationally representative US elderly population. Am J Public Health 2008; 98:1215–20.
[95] Stine-Morrow EA, Parisis JM, Morrow DG, Park DC. The effects of an engaged lifestyle on cognitive vitality: A field experiment. Psychol Aging 2008; 23:778–86.
[96] Karp A, Paillard-Borg S, Wang HX, Silverstein M, Winblad B, Fratiglioni L. Mental, physical and social components in leisure activities equally contribute to decrease dementia risk. Dement Geriatr Cogn Disord 2006; 21:65–73.
[97] Barnes LL, Mendes de Leon CF, Wilson RS, Bienias JL, Evans DA. Social resources and cognitive decline in a population of older African Americans and whites. Neurology 2004; 63:2322–6.
[98] Holtzman RE, Rebok GW, Saczynski JS, Kouzis AC, Wilcox Doyle K, Eaton WW. Social network characteristics and cognition in middle-aged and older adults. J  Gerontol B Psychol Sci Soc Sci 2004; 59:P278–84.
[99] Scarmeas N, Levy G, Tang MX, Manly J, Stern Y. Influence of leisure activity on the incidence of Alzheimer’s disease. Neurology 2001; 57:2236–42.
[100] Crooks VC, Lubben J, Petitti DB, Little D, Chiu V. Social network, cognitive function, and dementia incidence among elderly women. Am J Public Health 2008; 98:1221–7.
[101] Seeman TE, Miller-Martinez DM, Stein Merkin S, Lachman ME, Tun PA, Karlamangla AS. Histories of social engagement and adult cognition: Midlife in the U.S. study. J Gerontol B Psychol Sci Soc Sci 2011; 66(Supplement 1):i141–52.
[102] Brown CL, Gibbons LE, Kennison RF, Robitaille A, Lindwall M, Mitchell MB, et al. Social activity and cognitive functioning over time: a coordinated analysis of four longitudinal studies. J Aging Res 2012; 2012:287438.
[103] Meng X, D’Arcy C. Education and dementia in the context of the cognitive reserve hypothesis: a systematic review with metaanalyses and qualitative analyses. PLoS One 2012; 7:e38268.
[104] Jefferson AL, Gibbons LE, Rentz DM, Carvalho JO, Manly J, Bennett DA, et al. A life course model of cognitive activities, socioeconomic status, education, reading ability, and cognition. JAm Geriatr Soc 2011; 59:1403–11.
[105] Fitzpatrick AL, Kuller LH, Ives DG, Lopez OL, Jagust W, Breitner JC, et al. Incidence and prevalence of dementia in the Cardiovascular Health Study. J Am Geriatr Soc 2004; 52:195–204.
[106] Kukull WA, Higdon R, Bowen JD, McCormick WC, Teri L, Schellenberg GD, et al. Dementia and Alzheimer disease incidence: A prospective cohort study. Arch Neurol 2002; 59:1737–46.
[107] Evans DA, Bennett DA, Wilson RS, Bienias JL, Morris MC, Scherr PA, et al. Incidence of Alzheimer disease in a biracial urban community: Relation to apolipoprotein E allele status. Arch Neurol 2003; 60:185–9.
[108] Stern Y, Gurland B, Tatemichi TK, Tang MX, Wilder D, Mayeux R. Influence of education and occupation on the incidence of Alzheimer’s disease. JAMA 1994; 271:1004–10.
[109] Evans DA, Hebert LE, Beckett LA, Scherr PA, Albert MS, Chown MJ, et al. Education and other measures of socioeconomic status and risk of incident Alzheimer disease in a defined population of older persons. Arch Neurol 1997; 54:1399–405.
[110] Sando SB, Melquist S, Cannon A, Hutton M, Sletvoid O, Saltvedt I, et al. Risk-reducing effect of education in Alzheimer’s disease. Int J Geriatr Psychiatry 2008; 23:1156–62.
[111] Caamano-Isorna F, Corral M, Montes-Martinez A, Takkouche B. Education and dementia: a meta-analytic study. Neuroepidemiology 2006; 26:226–32.
[112] Lye TC, Shores EA. Traumatic brain injury as a risk factor for Alzheimer’s disease: A review. Neuropsychol Rev 2000; 10:115–29.
[113] Plassman BL, Havlik RJ, Steffens DC, Helms MJ, Newman TN, Drosdick D, et al. Documented head injury in early adulthood and risk of Alzheimer’s disease and other dementias. Neurology 2000; 55:1158–66.
[114] Barnes DE, Kaup A, Kirby KA, Byers AL, Diaz-Arrastia R, Yaffe K. Traumatic brain injury and risk of dementia in older veterans. Neurology 2014; 83:312–9.
[115] Gardner R, Yaffe K. Traumatic brain injury may increase risk of young onset dementia. Ann Neurol 2014; 75:339–41.
[116] Fleminger S, Oliver DL, Lovestone S, Rabe-Hesketh S, Giora A. Head injury as a risk factor forAlzheimer’s disease: the evidence10 years on; a partial replication. J Neurol Neurosurg Psychiatry 2003; 74:857–62.
[117] Shively S, Scher AI, Perl DP, Diaz-Arrastia R. Dementia resulting from traumatic brain injury: what is the pathology? Arch Neurol 2012; 69:1245–51.
[118] Smith DH, Johnson VE, StewartW. Chronic neuropathologies of single and repetitive TBI: Substrates of dementia? Nat Rev Neurol 2013; 9:211–21.
[119] Guskiewicz KM. Association between recurrent concussion and late life cognitive impairment in retired professional football players. Neurosurgery 2005; 57:719–26.
[120] Institute for Social Research. National Football League Player Care Foundation Study of NFL Retired Players. Ann Arbor: University of Michigan; 2009.
[121] Lehman EJ, Hein MJ, Baron SL, Gersix CM. Neurodegenerative causes of death among retired National Football League players. Neurology 2012; 79:1970–4.
[122] Groswasser Z, Reider-Groswasser II, Schwab K, Ommaya AK, Pridgen A, Brown HR, et al. Quantitative imaging in late TBI. Part II: Cognition and work after closed and penetrating head injury: A report of the Vietnam Head Injury Study. Brain Inj 2002; 16:681–90.
[123] Salazar AM, Warden DL, Schwab K, Spector J, Braverman S, Walter J, et al. Cognitive rehabilitation for traumatic brain injury: A randomized trial. Defense and Veterans Head Injury Program (DVHIP) Study Group. JAMA 2000; 283:3075–81.
[124] Roberts GW, Allsop D, Bruton C. The occult aftermath of boxing. J Neurol Neurosurg Psychiatry 1990; 53:373–8.
[125] Ownby RL, Crocco E,AcevedoA, JohnV, Loewenstein D. Depression and risk for Alzheimer disease: Systematic review, meta-analysis, and metaregression analysis. Arch Gen Psychiatry 2006; 63:530–8.
[126] Diniz BS, Butters MA, Albert SM, Dew MA, Reynolds CF 3rd. Latelife depression and risk of vascular dementia and Alzheimer’s disease: Systematic review and meta-analysis of community-based cohort studies. Br J Psychiatry 2013; 202:329–35.
[127] Barnes DE, Yaffe K, Byers AL, McCormick M, Schaefer C, Whitmer RA. Midlife vs late-life depressive symptoms and risk of dementia: Differential effects for Alzheimer disease and vascular dementia. Arch Gen Psychiatry 2012; 69:493–8.
[128] Wilson RS, Capuano AW, Boyle PA, Hoganson GM, Hizel LP, Shah RC, et al. Clinical-pathologic study of depressive symptoms and cognitive decline in old age. Neurology 2014; 83:702–9.
[129] Yaffe K, Laffan AM, Harrison SL, Redline S, Spira AP, Ensrud KE, et al. Sleep-disordered breathing, hypoxia, and risk of mild cognitive impairment and dementia in older women. JAMA 2011; 306:613–9.
[130] Ju YE, Lucey BP, Holtzman DM. Sleep and Alzheimer disease pathology—a bidirectional relationship. Nat Rev Neurol 2014; 10:115–9.
[131] ChangWP, Liu ME, Chang WC,Yang AC, Ku YC, Pai JT, et al. Sleep apnea and the risk of dementia: A population-based 5-year follow-up study in Taiwan. PLoS One 2013; 8:e78655.
[132] Chen PL, Lee WJ, Sun WZ, Oyang YJ, Fuh JL. Risk of dementia in patients with insomnia and long-term use of hypnotics: A population based retrospective cohort study. PLoS One 2012; 7:e49113.
[133] Sterniczuk R, Theou O, Rusak B, Rockwood K. Sleep disturbance is associated with incident dementia and mortality. Curr Alzheimer Res 2013; 10:767–75.
[134] Osorio RS, Gumb T, Pirraglia E, Varga AW, Lu SE, Lim J, et al. Sleep-disordered breathing advances cognitive decline in the elderly. Neurology 2015; 84:1964–71.
[135] Yaffe K, Falvey CM, Hoang T. Connections between sleep and cognition in older adults. Lancet Neurol 2014; 13:1017–28.
[136] Lim AS, Kowgier M, Yu L, Buchman AS, Bennett DA. Sleep fragmentation and the risk of incident Alzheimer’s disease and cognitive decline in older persons. Sleep 2013; 36:1027–32.
[137] Potvin O, Lorrain D, Forget H, Dube M, Grenier S, Preville M, et al. Sleep quality and 1-year incident cognitive impairment in community-dwelling older adults. Sleep 2012; 35:491–9.
[138] Satizabal CL, Beiser A, Chene G, Chouraki VA, Himali JJ, Preis SR, et al. Temporal trends in dementia incidence in the Framingham Study. Alzheimers Dement 2014; 10(4 Supplement):P296.
[139] Schrijvers EM, Verhaaren BF, Koudstaal PJ, Hofman A, Ikram MA, Breteler MM. Is dementia incidence declining?: Trends in dementia incidence since 1990 in the Rotterdam Study. Neurology 2012; 78:1456–63.
[140] Qiu C, von Strauss E, Backman L,Winblad B, Fratiglioni L. Twenty year changes in dementia occurrence suggest decreasing incidence in central Stockholm, Sweden. Neurology 2013; 80:1888–94.
[141] Dodge HH, Zhu J, Lee CW, Chang CC, Ganguli M. Cohort effects in age-associated cognitive trajectories. J Gerontol A Biol Sci Med Sci 2014; 69:687–94.
[142] Doblhammer G, Fink A, Fritze T. Short-term trends in dementia prevalence in Germany between the years 2007 and 2009. Alzheimers Dement 2015; 11:291–9.
[143] Elwood P, Galante J, Pickering J, Palmer S, Bayer A, Ben-Shlomo Y, et al. Healthy lifestyles reduce the incidence of chronic diseases and dementia: evidence from the Caerphilly cohort study. PLoS One 2013; 8:e81877.
[144] Larson EB, Yaffe K, Langa KM. New insights into the dementia epidemic. N Engl J Med 2013; 369:2275–7.
[145] Middleton LE, Yaffe K. Targets for the prevention of dementia. J Alzheimers Dis 2010; 20:915–24.
[146] Roberts RO, Cha RH, Mielke MM, Geda YE, Boeve BF, Machulda MM, et al. Risk and protective factors for cognitive impairment in persons aged 85 years and older. Neurology 2015; 84:1854–61.
[147] Mangialasche F, Kivipelto M, Solomon A, Fratiglioni L. Dementia prevention: current epidemiological evidence and future perspective. Alzheimers Res Ther 2012; 4:6.
[148] Monsuez JJ, Gesquiere-Dando A, Rivera S. Cardiovascular prevention of cognitive decline. Cardiol Res Pract 2011; 2011:250970.
[149] Ngandu T, Lehtisalo J, Solomon A, Levalahti E, Ahtiluoto RA, Backman L, et al. A 2-year multidomain intervention of diet, exercise, cognitive training, and vascular risk monitoring versus control to prevent cognitive decline in at-risk elderly people (FINGER): a randomised controlled trial. Lancet 2015; http://dx.doi.org/10.1016/
S0140–6736(15)60461-5. Epub ahead of print.
[150] Institute of Medicine. Cognitive Aging: Progress in Understanding and Opportunity for Action. Washington, DC: The National Academies Press; 2015.
[151] World Dementia Council. WDC Dementia Risk Reduction Statement. Available at: https://s3-eu-west-1.amazonaws.com/media. dh.gov.uk/network/353/files/2015/01/WDC-supportive-statement-on risk-reduction-FINAL-FOR-PUBLICATION-BRANDED-150128-LM.pdf. Accessed on April 7, 2015.